Vadodara, India

Gaurav Kulkarni

USPTO Granted Patents = 2 

Average Co-Inventor Count = 8.9

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Gujarat, IN (2017)
  • Vadodara, IN (2019)

Company Filing History:


Years Active: 2017-2019

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Gaurav Kulkarni: Innovator in Pharmaceutical Chemistry

Introduction

Gaurav Kulkarni is a notable inventor based in Vadodara, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of processes for the synthesis of important compounds.

Latest Patents

Gaurav Kulkarni holds two patents that showcase his innovative work. The first patent is titled "Processes for preparation of Sugammadex and intermediates thereof." This invention relates to a process for preparing 6-perdeoxy-6-per-chloro gamma-cyclodextrin, a key intermediate useful in the synthesis of Sugammadex sodium. The patent further details a process for the preparation and purification of Sugammadex sodium. The second patent is titled "Methods of making carfilzomib and intermediates thereof." This patent discloses racemization-free methods for synthesizing carfilzomib, along with novel intermediates and methods employing fragment condensation.

Career Highlights

Throughout his career, Gaurav Kulkarni has worked with various companies, including Apicore US LLC. His expertise in pharmaceutical processes has positioned him as a valuable asset in the industry.

Collaborations

Gaurav has collaborated with notable professionals in his field, including Talluri Bhushaiah Chowdary and Anand Vijaykumar Mantri. These collaborations have further enhanced his contributions to pharmaceutical innovations.

Conclusion

Gaurav Kulkarni is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in drug synthesis. His patents reflect his commitment to innovation and the development of effective pharmaceutical processes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…